ANTI-PD-L1 ANTIBODIES

Multispecific antibody having a binding site for ICOS and a binding site for a second antigen, e.g., an immune checkpoint molecule such as PD-L1. Use of the multispecific antibody in immuno-oncology, including for treatment of solid tumours.

Saved in:
Bibliographic Details
Main Authors GALLAGHER, Thomas, SANDY, Nikole, GERMASCHEWSKI, Volker, ARKINSTALL, Stephen John, VAN KRINKS, Cassandra, GILLIES, Stephen, CAMPBELL, Jamie, KIRBY, Ian, DEANTONIO, Cecilia, KOSMAC, Miha
Format Patent
LanguageEnglish
Published 28.12.2018
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Multispecific antibody having a binding site for ICOS and a binding site for a second antigen, e.g., an immune checkpoint molecule such as PD-L1. Use of the multispecific antibody in immuno-oncology, including for treatment of solid tumours.
Bibliography:Application Number: SG20181110509P